Medicis Pharmaceutical Corp (MRX) Tops Q1 EPS by 1c; Issues Outlook

May 5, 2011 4:09 PM

Medicis Pharmaceutical Corp (NYSE: MRX) reported Q1 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found